Sign in
4

Changes in Ownership

Faeth Therapeutics, Inc. Filed Acc 0001567619-22-001340

10% owner bought 10,000 shares at $5.08 ($50,800)

From the SEC's structured data for this filing

Trades in this filing

Cambrian BioPharma Inc · 10% owner

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-01-18 Purchase : show line 1 in the form +10,000 $5.08 $50,800 4,985,632 D
Open-market purchases · 10,000 sh · avg $5.08 · $50,800
Loading xslF345X03/doc1.xml…